Hyperfine, Inc. (HYPR)
USD 0.69
(-6.01%)
USD 0.69
(-6.01%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -47.06 Million USD | 35.41% |
| 2022 | -72.85 Million USD | -13.59% |
| 2021 | -64.14 Million USD | -176.45% |
| 2020 | -23.2 Million USD | -17.02% |
| 2019 | -19.82 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -10.59 Million USD | -1.98% |
| 2024 Q1 | -10.38 Million USD | 8.61% |
| 2023 Q3 | -11.48 Million USD | -0.42% |
| 2023 FY | - USD | 35.41% |
| 2023 Q1 | -12.78 Million USD | 4.39% |
| 2023 Q4 | -11.36 Million USD | 1.0% |
| 2023 Q2 | -11.43 Million USD | 10.55% |
| 2022 Q2 | -22.92 Million USD | 2.5% |
| 2022 Q4 | -13.36 Million USD | -2.48% |
| 2022 Q3 | -13.04 Million USD | 43.11% |
| 2022 FY | - USD | -13.59% |
| 2022 Q1 | -23.51 Million USD | 8.67% |
| 2021 FY | - USD | -176.45% |
| 2021 Q4 | -25.75 Million USD | -58.76% |
| 2021 Q3 | -16.21 Million USD | -12.13% |
| 2021 Q2 | -14.46 Million USD | -87.62% |
| 2021 Q1 | -7.7 Million USD | -13.79% |
| 2020 Q2 | -5.42 Million USD | 0.0% |
| 2020 Q1 | -5.42 Million USD | 0.0% |
| 2020 Q3 | -5.57 Million USD | -2.63% |
| 2020 Q4 | -6.77 Million USD | -21.61% |
| 2020 FY | - USD | -17.02% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -248.936% |
| Cerus Corporation | -26.53 Million USD | -77.348% |
| OrthoPediatrics Corp. | -8.38 Million USD | -461.52% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -348.435% |
| Talis Biomedical Corporation | -66.04 Million USD | 28.744% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -182.225% |
| Inogen, Inc. | -45.67 Million USD | -3.025% |
| Spectral AI, Inc. | -12.26 Million USD | -283.795% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 1.325% |
| CVRx, Inc. | -38.73 Million USD | -21.507% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1233.929% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -288.709% |
| Orthofix Medical Inc. | -86.98 Million USD | 45.898% |
| Venus Concept Inc. | -26.11 Million USD | -80.221% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 5.445% |
| Bioventus Inc. | -23.07 Million USD | -103.992% |
| BrainsWay Ltd. | -2.31 Million USD | -1936.391% |
| Envoy Medical, Inc. | -18.23 Million USD | -158.038% |
| electroCore, Inc. | -17.76 Million USD | -164.983% |
| IceCure Medical Ltd | -15.25 Million USD | -208.536% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 5.407% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -179.199% |
| MaxCyte, Inc. | -44.12 Million USD | -6.647% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -300.315% |
| Nexalin Technology, Inc. | -5.69 Million USD | -726.786% |
| PAVmed Inc | -75.74 Million USD | 37.867% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 12.458% |
| RxSight, Inc. | -41.03 Million USD | -14.679% |
| Sight Sciences, Inc. | -49.41 Million USD | 4.764% |
| SI-BONE, Inc. | -34.44 Million USD | -36.623% |
| TELA Bio, Inc. | -40.63 Million USD | -15.82% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 19.275% |
| Treace Medical Concepts, Inc. | -39 Million USD | -20.644% |
| LivaNova PLC | 39.01 Million USD | 220.62% |
| 908 Devices Inc. | -34.02 Million USD | -38.313% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 57.446% |
| Nemaura Medical Inc. | -7.28 Million USD | -545.816% |
| NeuroPace, Inc. | -22.83 Million USD | -106.101% |
| LENSAR, Inc. | -8.71 Million USD | -440.062% |
| Apyx Medical Corporation | -18.11 Million USD | -159.833% |
| Cutera, Inc. | -136.56 Million USD | 65.538% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1292.337% |
| BioSig Technologies, Inc. | -28.15 Million USD | -67.173% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1970.469% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -124.217% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 112.269% |
| Axonics, Inc. | 7.77 Million USD | 705.286% |
| Outset Medical, Inc. | -153.78 Million USD | 69.399% |
| IRIDEX Corporation | -7.44 Million USD | -531.861% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 52.025% |
| IRadimed Corporation | 20.8 Million USD | 326.248% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -483.739% |
| INVO Bioscience, Inc. | -6.88 Million USD | -584.024% |
| Telesis Bio, Inc. | -40.49 Million USD | -16.22% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 228.312% |
| Varex Imaging Corporation | 67.2 Million USD | 170.031% |
| Quipt Home Medical Corp. | 44.07 Million USD | 206.785% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -332.944% |
| Pulmonx Corporation | -55.09 Million USD | 14.577% |
| Dynatronics Corporation | -976 Thousand USD | -4721.784% |
| Modular Medical, Inc. | -17.1 Million USD | -175.162% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -224.895% |
| Semler Scientific, Inc. | 23.58 Million USD | 299.504% |
| InMode Ltd. | 196.28 Million USD | 123.976% |
| Bruker Corporation | 599 Million USD | 107.857% |
| Cytosorbents Corporation | -28.81 Million USD | -63.345% |
| DexCom, Inc. | 916.7 Million USD | 105.134% |
| Align Technology, Inc. | 799.03 Million USD | 105.89% |
| Viveve Medical, Inc. | -20.61 Million USD | -128.263% |
| ZimVie Inc. | 91.07 Million USD | 151.674% |
| Movano Inc. | -29.12 Million USD | -61.583% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -967.627% |
| Nexalin Technology, Inc. | -5.69 Million USD | -726.786% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1233.929% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 75.824% |
| Profound Medical Corp. | -27.12 Million USD | -73.507% |
| Insulet Corporation | 323.6 Million USD | 114.543% |
| enVVeno Medical Corporation | -25.01 Million USD | -88.109% |
| Surmodics, Inc. | 1.18 Million USD | 4061.364% |
| iCAD, Inc. | -6.56 Million USD | -616.847% |
| Nuwellis, Inc. | -16.35 Million USD | -187.729% |
| Biotricity, Inc. | -8.82 Million USD | -433.072% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 51.414% |
| Aethlon Medical, Inc. | -11.84 Million USD | -297.169% |
| InspireMD, Inc. | -20.91 Million USD | -125.054% |
| PAVmed Inc. | -75.74 Million USD | 37.867% |
| BIOLASE, Inc. | -15.13 Million USD | -210.859% |
| Beyond Air, Inc. | -59.03 Million USD | 20.277% |
| FONAR Corporation | 28.25 Million USD | 266.578% |
| AxoGen, Inc. | -13.32 Million USD | -253.099% |
| Vivani Medical, Inc. | -26.6 Million USD | -76.868% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 291.765% |
| Inari Medical, Inc. | 7.11 Million USD | 761.62% |
| UFP Technologies, Inc. | 72.74 Million USD | 164.695% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1289.958% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -664.474% |
| Tenon Medical, Inc. | -15.52 Million USD | -203.072% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -208.273% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -13.466% |
| AdaptHealth Corp. | -171.09 Million USD | 72.494% |
| Sintx Technologies, Inc. | -6.6 Million USD | -613.045% |
| NanoVibronix, Inc. | -3.43 Million USD | -1270.044% |
| Quanterix Corporation | -38.08 Million USD | -23.559% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -332.944% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 156970.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 83.028% |
| TransMedics Group, Inc. | -7.6 Million USD | -518.979% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -116.223% |
| NeuroMetrix, Inc. | -7.09 Million USD | -563.222% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 19.288% |
| Biomerica, Inc. | -5.99 Million USD | -685.266% |
| Bone Biologics Corporation | 479.57 Thousand USD | 9913.125% |
| AVITA Medical, Inc. | -39.56 Million USD | -18.938% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -413.042% |
| Silk Road Medical, Inc | -45.08 Million USD | -4.394% |